Customise your Experience
Select areas of interest to create an account and personalise your Campus experience
More about Science
Choose a therapeutic area to find related scientific content
Dyslipidaemia
Explore Content
Explore the most recently added content
Prescribing Information can be found through the links in the Product Cards at the bottom of the page
.jpg/jcr:content/thumbnail%20(3).jpg 767w, /.imaging/webp/sanofi-platform/img400x300/dam/hcp-portal-ie/Science/Dyslipidemia/thumbnail-(3).jpg/jcr:content/thumbnail%20(3).jpg 1200w)
.jpg/jcr:content/thumbnail%20(2).jpg 767w, /.imaging/webp/sanofi-platform/img400x300/dam/hcp-portal-ie/Science/Dyslipidemia/thumbnail-(2).jpg/jcr:content/thumbnail%20(2).jpg 1200w)
.jpg/jcr:content/thumbnail%20(1).jpg 767w, /.imaging/webp/sanofi-platform/img400x300/dam/hcp-portal-ie/Science/Dyslipidemia/thumbnail-(1).jpg/jcr:content/thumbnail%20(1).jpg 1200w)
What is the efficacy and safety profile of Ezetimibe/Rosuvastatin combination?
Suvezen® (rosuvastatin/ezetimibe)
Dyslipidaemia guidelines interactive tool
2 minutes
Suvezen® (rosuvastatin/ezetimibe)
Praluent (alirocumab)
Dyslipidaemia guidelines interactive tool
20 minutes
Suvezen® (rosuvastatin/ezetimibe)
Praluent (alirocumab)
Dyslipidaemia guidelines interactive tool
1 hour
Suvezen® (rosuvastatin/ezetimibe)
Praluent (alirocumab)
Our Products
.png/jcr:content/Untitled%20design%20(3).png 767w, /.imaging/webp/sanofi-platform/img620x465/dam/hcp-portal-ie/Product-Portfolio/Landing-Page/Untitled-design-(3).png/jcr:content/Untitled%20design%20(3).png 1200w)
Click here for Prescribing Information
MAT-IE-2300173 (v2.0)
Date of preparation: September 2023
Praluent®
alirocumab
Click here for Prescribing Information
MAT-IE-2300218 (v1.0)
Date of preparation: April 2023
MAT-IE-2300163 (v1.0)
Date of preparation: April 2023
YOU ARE NOW LEAVING SANOFI CAMPUS IRELAND
You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.
Welcome to Sanofi Campus Ireland
This site is intended for Healthcare Professionals in the Republic of Ireland and contains information on Sanofi Ireland’s medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a Healthcare Professional in the Republic of Ireland. This site contains promotional information.
MAT-IE-2300185 (v2.0)
Date of Preparation: June 2023